Learn More
Medchemexpress LLC Olodaterol (BI1744) | 868049-49-4 | 99.9% | C21H26N2O5 | 50 MG

Supplier: Medchemexpress LLC HY1430150MG
Olodaterol (BI1744) is a selective, long-acting β2-adrenoceptor (β2-AR) agonist with an EC50 of 0.1 nM and a pKi of 9.14 for human β2-adrenoceptor. It is used for chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. Olodaterol exhibits subnanomolar affinity for the β2-AR and is selective compared to β1-AR and β3-AR subtypes.
- Attenuates growth factor-induced motility and proliferation in fibroblasts.
- Interferes with FGF-induced phosphorylation of signaling cascades.
- Increases intracellular cAMP in a concentration-dependent manner.
- Inhibits PICP increase with maximal efficacy of 70% at 10 nM.
- Accelerates body weight recovery and attenuates TGF-β-induced lung fibrosis in C57BL/6 mice.
- Induces a dose-dependent bronchoprotection in guinea pigs and dogs.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.